The Oncology Institute, Inc. TOI Common stock issuance for private placement
Common stock issuance for private placement at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s common stock issuance for private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s common stock issuance for private placement?
- The Oncology Institute, Inc. (TOI) reported common stock issuance for private placement of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s common stock issuance for private placement changed year-over-year?
- The Oncology Institute, Inc.'s common stock issuance for private placement decreased by 100.0% year-over-year, from $15.36M to $0.
- What does common stock issuance for private placement mean?
- Represents the cash inflows generated from the sale of equity or debt securities directly to a select group of private investors. This metric serves as a key indicator of the company's ability to raise capital outside of public markets to fund operations or growth initiatives.